TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2028

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2028

  • Category:Life Sciences
  • Published on : 23 July 2022
  • Pages :99
  • Formats:
  • Report Code:SMR-7229768
OfferClick for best price

Best Price: $3920

Nonsteroidal Antiinflammatory Drugs NSAID Market Size, Share 2022


Market Analysis and Insights: Global Nonsteroidal Antiinflammatory Drugs NSAID Market

The global Nonsteroidal Antiinflammatory Drugs NSAID market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Antiinflammatory Drugs NSAID market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Antiinflammatory Drugs NSAID market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Antiinflammatory Drugs NSAID market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Antiinflammatory Drugs NSAID market.

Global Nonsteroidal Antiinflammatory Drugs NSAID Scope and Market Size

Non-steroidal Anti-inflammatory Drugs (NSAID) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-steroidal Anti-inflammatory Drugs (NSAID) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Salicylates

Propionic acid derivatives

Acetic acid derivatives

Enolic acid (Oxicam) derivatives

Anthranilic acid derivatives (Fenamates)

Selective COX-2 inhibitors (Coxibs)

Sulfonanilides

Segment by Application

Human

Animals

Others

By Company

Bayer

Ecotrin

Generic

St. Joseph

Elanco

Zoetis

Boehringer Ingelheim

Merial

Merck Animal Health

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Nonsteroidal Antiinflammatory Drugs NSAID product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Nonsteroidal Antiinflammatory Drugs NSAID, with price, sales, revenue, and global market share of Nonsteroidal Antiinflammatory Drugs NSAID from 2019 to 2022.

Chapter 3, the Nonsteroidal Antiinflammatory Drugs NSAID competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nonsteroidal Antiinflammatory Drugs NSAID breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Nonsteroidal Antiinflammatory Drugs NSAID market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Nonsteroidal Antiinflammatory Drugs NSAID.

Chapter 13, 14, and 15, to describe Nonsteroidal Antiinflammatory Drugs NSAID sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Nonsteroidal Antiinflammatory Drugs NSAID Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 99 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
1.2 Market by Type
1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Salicylates
1.2.3 Propionic acid derivatives
1.2.4 Acetic acid derivatives
1.2.5 Enolic acid (Oxicam) derivatives
1.2.6 Anthranilic acid derivatives (Fenamates)
1.2.7 Selective COX-2 inhibitors (Coxibs)
1.2.8 Sulfonanilides
1.3 Market by Application
1.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human
1.3.3 Animals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Estimates and Forecasts 2017-2028
2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Estimates and Forecasts 2017-2028
2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
2.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022)
2.4.2 Global Sales Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2023-2028)
2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
2.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022)
2.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
3.1.1 Global Top Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers by Sales (2017-2022)
3.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in 2021
3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
3.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022)
3.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
3.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type
4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Type (2017-2022)
4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Type (2023-2028)
4.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type
4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Type (2017-2022)
4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type
4.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022)
4.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Sales by Application (2017-2022)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Sales by Application (2023-2028)
5.1.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application
5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Historical Revenue by Application (2017-2022)
5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application
5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022)
5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
6.2.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
6.2.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
6.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
6.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
7.2.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
7.2.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
7.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
7.3.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
8.2.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
8.2.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region
8.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2028)
8.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
9.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
9.2.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
9.2.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
9.3 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
9.3.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
9.3.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type
10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2028)
10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application
10.2.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2028)
10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Country
10.3.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Ecotrin
11.2.1 Ecotrin Corporation Information
11.2.2 Ecotrin Overview
11.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ecotrin Recent Developments
11.3 Generic
11.3.1 Generic Corporation Information
11.3.2 Generic Overview
11.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Generic Recent Developments
11.4 St. Joseph
11.4.1 St. Joseph Corporation Information
11.4.2 St. Joseph Overview
11.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 St. Joseph Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Overview
11.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Elanco Recent Developments
11.6 Zoetis
11.6.1 Zoetis Corporation Information
11.6.2 Zoetis Overview
11.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zoetis Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Corporation Information
11.7.2 Boehringer Ingelheim Overview
11.7.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Merial
11.8.1 Merial Corporation Information
11.8.2 Merial Overview
11.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial Recent Developments
11.9 Merck Animal Health
11.9.1 Merck Animal Health Corporation Information
11.9.2 Merck Animal Health Overview
11.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Animal Health Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Analysis
12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Production Mode & Process
12.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Marketing
12.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Channels
12.4.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors
12.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Trends
13.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
13.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
13.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
14 Key Findings in The Global Non-steroidal Anti-inflammatory Drugs (NSAID) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Salicylates
Table 3. Major Manufacturers of Propionic acid derivatives
Table 4. Major Manufacturers of Acetic acid derivatives
Table 5. Major Manufacturers of Enolic acid (Oxicam) derivatives
Table 6. Major Manufacturers of Anthranilic acid derivatives (Fenamates)
Table 7. Major Manufacturers of Selective COX-2 inhibitors (Coxibs)
Table 8. Major Manufacturers of Sulfonanilides
Table 9. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2023-2028)
Table 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2017-2022)
Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2023-2028)
Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2017-2022)
Table 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2017-2022)
Table 23. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2021)
Table 26. Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Offered
Table 28. Date of Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs (NSAID) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 31. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 32. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2017-2022)
Table 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2023-2028)
Table 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2017-2022)
Table 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2023-2028)
Table 38. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Type (2017-2022) & (USD/Unit)
Table 39. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2017-2022)
Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2023-2028)
Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2017-2022)
Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Application (2023-2028)
Table 48. Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2017-2022) & (USD/Unit)
Table 49. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 50. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 51. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 52. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 55. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 56. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 59. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 60. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 63. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 64. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 67. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 68. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 71. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 72. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 75. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 76. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 79. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 80. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2017-2022) & (K Units)
Table 83. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2023-2028) & (K Units)
Table 84. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 87. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 88. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 91. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 92. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 95. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 96. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2017-2022) & (K Units)
Table 99. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2023-2028) & (K Units)
Table 100. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2017-2022) & (K Units)
Table 103. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2023-2028) & (K Units)
Table 104. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2017-2022) & (K Units)
Table 107. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2023-2028) & (K Units)
Table 108. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Major Businesses
Table 112. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Recent Developments
Table 115. Ecotrin Corporation Information
Table 116. Ecotrin Description and Major Businesses
Table 117. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Ecotrin Recent Developments
Table 120. Generic Corporation Information
Table 121. Generic Description and Major Businesses
Table 122. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Generic Recent Developments
Table 125. St. Joseph Corporation Information
Table 126. St. Joseph Description and Major Businesses
Table 127. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. St. Joseph Recent Developments
Table 130. Elanco Corporation Information
Table 131. Elanco Description and Major Businesses
Table 132. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Elanco Recent Developments
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Major Businesses
Table 137. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Zoetis Recent Developments
Table 140. Boehringer Ingelheim Corporation Information
Table 141. Boehringer Ingelheim Description and Major Businesses
Table 142. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Boehringer Ingelheim Recent Developments
Table 145. Merial Corporation Information
Table 146. Merial Description and Major Businesses
Table 147. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial Recent Developments
Table 150. Merck Animal Health Corporation Information
Table 151. Merck Animal Health Description and Major Businesses
Table 152. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Merck Animal Health Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List
Table 158. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List
Table 159. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Trends
Table 160. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Drivers
Table 161. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Challenges
Table 162. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Product Picture
Figure 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Type in 2021 & 2028
Figure 3. Salicylates Product Picture
Figure 4. Propionic acid derivatives Product Picture
Figure 5. Acetic acid derivatives Product Picture
Figure 6. Enolic acid (Oxicam) derivatives Product Picture
Figure 7. Anthranilic acid derivatives (Fenamates) Product Picture
Figure 8. Selective COX-2 inhibitors (Coxibs) Product Picture
Figure 9. Sulfonanilides Product Picture
Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Application in 2021 & 2028
Figure 11. Human
Figure 12. Animals
Figure 13. Others
Figure 14. Non-steroidal Anti-inflammatory Drugs (NSAID) Report Years Considered
Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2017-2028 (K Units)
Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2017-2028 (US$ Million)
Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2017-2022)
Figure 20. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2023-2028)
Figure 21. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 22. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Non-steroidal Anti-inflammatory Drugs (NSAID) in the World: Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2021
Figure 33. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 35. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 36. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 37. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 38. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 39. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 40. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 41. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 42. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 43. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 44. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 47. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 48. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 49. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 50. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 51. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 52. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 53. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Region (2017-2028)
Figure 63. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 66. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 74. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 76. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 78. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 79. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Country (2017-2028)
Figure 88. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (2017-2028) & (US$ Million)
Figure 91. Non-steroidal Anti-inflammatory Drugs (NSAID) Value Chain
Figure 92. Non-steroidal Anti-inflammatory Drugs (NSAID) Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount